These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25802993)

  • 21. Number of animals used for experimental purposes lower in the European Union.
    von Aulock S
    ALTEX; 2014; 31(1):1. PubMed ID: 24600696
    [No Abstract]   [Full Text] [Related]  

  • 22. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for animal care committees and animal use oversight.
    Richmond J; Fletch A; Van Tongerloo R
    ILAR J; 2002; 43 Suppl():S129-32. PubMed ID: 12388867
    [No Abstract]   [Full Text] [Related]  

  • 23. An assessment of some recommendations made concerning the OECD Health Effects Test Guidelines.
    Auletta A
    Altern Lab Anim; 2006 Feb; 34(1):109-10. PubMed ID: 16522153
    [No Abstract]   [Full Text] [Related]  

  • 24. The flaws and human harms of animal experimentation.
    Akhtar A
    Camb Q Healthc Ethics; 2015 Oct; 24(4):407-19. PubMed ID: 26364776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The OECD health effects test guidelines: a challenge to the sincerity of commitment to the three Rs.
    Balls M; Combes RD
    Altern Lab Anim; 2006 Feb; 34(1):105-8. PubMed ID: 16522152
    [No Abstract]   [Full Text] [Related]  

  • 26. The ethics of using animals in biomedical research: the findings of a working party of the Institute of Medical Ethics.
    Smith J
    Bull Med Ethics; 1991 Sep; No. 71():13-7. PubMed ID: 11659398
    [No Abstract]   [Full Text] [Related]  

  • 27. A new reductionism for animal research.
    Fisher C
    Altern Lab Anim; 1995; 23(3):318-31. PubMed ID: 11656568
    [No Abstract]   [Full Text] [Related]  

  • 28. The assessment of repeated dose toxicity in vitro: a proposed approach. The report and recommendations of ECVAM workshop 56.
    Prieto P; Baird AW; Blaauboer BJ; Castell Ripoll JV; Corvi R; Dekant W; Dietl P; Gennari A; Gribaldo L; Griffin JL; Hartung T; Heindel JJ; Hoet P; Jennings P; Marocchio L; Noraberg J; Pazos P; Westmoreland C; Wolf A; Wright J; Pfaller W
    Altern Lab Anim; 2006 Jun; 34(3):315-41. PubMed ID: 16831063
    [No Abstract]   [Full Text] [Related]  

  • 29. Assigning ethical weights to clinical signs observed during toxicity testing.
    Ringblom J; Törnqvist E; Hansson SO; Rudén C; Öberg M
    ALTEX; 2017; 34(1):148-156. PubMed ID: 27442998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Here I stand ... two key figures in the animal experiments debate draw different lessons from public attitudes.
    Blakemore C; Langley G
    New Sci; 1999 May; 162(2187):60-1. PubMed ID: 11657972
    [No Abstract]   [Full Text] [Related]  

  • 31. Better science with human cell-based organ and tissue models.
    Heinonen T
    Altern Lab Anim; 2015 Mar; 43(1):29-38. PubMed ID: 25802996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The first ten years of the Animals (Scientific Procedures) Act 1986.
    Fund for the Replacement of Animals in Medical Experiments (FRAME). Trustees
    Altern Lab Anim; 1996; 24(5):639-47. PubMed ID: 11660678
    [No Abstract]   [Full Text] [Related]  

  • 33. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for safety evaluation using nonrodent species.
    Weekley LB; Guittin P; Chamberland G
    ILAR J; 2002; 43 Suppl():S118-22. PubMed ID: 12388864
    [No Abstract]   [Full Text] [Related]  

  • 34. From 3Rs to 3D: In vitro alternative models for replacement.
    Nagy AL; Catoi C; Socaciu C; Pintea A; Oros NA; Coman C; Rugina D; Matea CT; Mocan T; Coccini T; De Simone U; De Angelis I; Bertero A; Sambuy Y; Caloni F
    ALTEX; 2018; 35(3):420-421. PubMed ID: 30008010
    [No Abstract]   [Full Text] [Related]  

  • 35. Replacing animal experimentation: not a question of if, but when, and by what route?
    Balls M
    Altern Lab Anim; 2002; 30(2):147-8. PubMed ID: 11971751
    [No Abstract]   [Full Text] [Related]  

  • 36. Working in partnership to advance the 3Rs in toxicity testing.
    Holmes AM; Creton S; Chapman K
    Toxicology; 2010 Jan; 267(1-3):14-9. PubMed ID: 19903508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal testing: more than a cosmetic change.
    Abbott A
    Nature; 2005 Nov; 438(7065):144-6. PubMed ID: 16281001
    [No Abstract]   [Full Text] [Related]  

  • 38. Incorporating the 3Rs into regulatory scientific practices.
    Sterling S; Rispin A
    ILAR J; 2002; 43 Suppl():S18-20. PubMed ID: 12388846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QSAR, Read-across and REACH.
    Barratt MD
    Altern Lab Anim; 2003 Nov; 31(5):463-5. PubMed ID: 15598173
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of ICCVAM in evaluating new and alternative test methods.
    Stokes WS; Hill RN
    Lab Anim (NY); 2002; 31(7):26-32. PubMed ID: 12200591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.